The Effect of Chemotherapy Induction Therapy on the Pancreas in Patients with Acute Lymphoblastic Leukemia

Overview

Journal Biomed Res Int

Publisher Wiley

Specialties Biomedical Engineering
Biotechnology
General Medicine

Date 2022 Aug 12

PMID 35958817

Authors

Temesgen Gebeyehu Wondmeneh

Ayal Tsegaye Mekonnen

Affiliations

Soon will be listed here.

Abstract

Background: The effect of chemotherapy induction on the pancreatic in patients with acute lymphoblastic leukemia is not described in Ethiopia. The study determined the chemotherapy drug-induced pancreatitis in patients with acute lymphoblastic leukemia.

Method: A preexperimental study (pretest and posttests) was conducted in forty patients with acute lymphoblastic leukemia. For some skewed data, a log transformation was computed. The back transformation was then calculated. Descriptive statistics and a mixed-model ANOVA were used to analyze the data. A post hoc Bonferroni test was used. A value < 0.05 was declared statistically significant.

Results: In this study, no clinically significant acute pancreatitis occurred. Elevated amylase and lipase levels, indicating grade 2 acute pancreatitis, were observed in 25% and 17.5% of patients, respectively. Amylase enzyme levels in children differed significantly from preinduction to the second week of induction ( = 0.001) and fourth week of induction ( = 0.001), as well as between the second and fourth weeks of induction ( = 0.033), but adults' amylase enzyme levels did not differ significantly ( = 0.2). Lipase levels in adults are nearly identical in all three measures, implying that there is no statistically significant difference ( = 0.775). However, the level of lipase enzyme in children was significantly higher from baseline to two and four weeks of induction ( = 0.007) but not between two and four weeks of induction ( = 0.129).

Conclusion: Clinically significant acute pancreatitis did not occur, but patients experienced mild (grade 2) acute pancreatitis. Amylase and lipase enzymes responded significantly to chemotherapy induction in children. Chemotherapy drugs should be given without altering pancreatic enzymes, specifically in children.

References

Elashtokhy H, Elgohary H, Eldeep B, Gaber S, Elbedewy T . Retrospective study of Dana Farber Consortium Protocol in newly diagnosed Egyptian adolescents and young adults with acute lymphoblastic leukemia: Tanta experience. J Egypt Natl Canc Inst. 2021; 33(1):9. DOI: 10.1186/s43046-021-00064-6. View

Quan W, Shao Q, Zhang H, Liu F, Zhang X . Acute Pancreatitis Associated with Valproate Treatment. Chin Med J (Engl). 2018; 131(15):1889-1890. PMC: 6071470. DOI: 10.4103/0366-6999.237390. View

McCormick M, Sharp E, Kalpatthi R, Zullo J, Gurtunca N, Zhang J . Hyperglycemia requiring insulin during acute lymphoblastic leukemia induction chemotherapy is associated with increased adverse outcomes and healthcare costs. Pediatr Blood Cancer. 2020; 67(9):e28475. PMC: 7674257. DOI: 10.1002/pbc.28475. View

Muniraj T, Gajendran M, Thiruvengadam S, Raghuram K, Rao S, Devaraj P . Acute pancreatitis. Dis Mon. 2012; 58(3):98-144. DOI: 10.1016/j.disamonth.2012.01.005. View

Liu C, Yang W, Devidas M, Cheng C, Pei D, Smith C . Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia. J Clin Oncol. 2016; 34(18):2133-40. PMC: 4962704. DOI: 10.1200/JCO.2015.64.5812. View

Ceppi F, Antillon F, Pacheco C, Sullivan C, Lam C, Howard S . Supportive medical care for children with acute lymphoblastic leukemia in low- and middle-income countries. Expert Rev Hematol. 2015; 8(5):613-26. DOI: 10.1586/17474086.2015.1049594. View

Balani A, Grendell J . Drug-induced pancreatitis : incidence, management and prevention. Drug Saf. 2008; 31(10):823-37. DOI: 10.2165/00002018-200831100-00002. View

Underwood T, Frye C . Drug-induced pancreatitis. Clin Pharm. 1993; 12(6):440-8. View

Bhatia M, Wong F, Cao Y, Lau H, Huang J, Puneet P . Pathophysiology of acute pancreatitis. Pancreatology. 2005; 5(2-3):132-44. DOI: 10.1159/000085265. View

10.

Treepongkaruna S, Thongpak N, Pakakasama S, Pienvichit P, Sirachainan N, Hongeng S . Acute pancreatitis in children with acute lymphoblastic leukemia after chemotherapy. J Pediatr Hematol Oncol. 2009; 31(11):812-5. DOI: 10.1097/MPH.0b013e3181b87035. View

11.

Nitsche C, Maertin S, Scheiber J, Ritter C, Lerch M, Mayerle J . Drug-induced pancreatitis. Curr Gastroenterol Rep. 2012; 14(2):131-8. DOI: 10.1007/s11894-012-0245-9. View

12.

Denton C, Rawlins Y, Oberley M, Bhojwani D, Orgel E . Predictors of hepatotoxicity and pancreatitis in children and adolescents with acute lymphoblastic leukemia treated according to contemporary regimens. Pediatr Blood Cancer. 2017; 65(3). PMC: 7522002. DOI: 10.1002/pbc.26891. View

13.

Banks P, Bollen T, Dervenis C, Gooszen H, Johnson C, Sarr M . Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2012; 62(1):102-11. DOI: 10.1136/gutjnl-2012-302779. View

14.

Chen C, Chang H, Chou S, Yang Y, Lu M, Jou S . Acute pancreatitis in children with acute lymphoblastic leukemia correlates with L-asparaginase dose intensity. Pediatr Res. 2021; 92(2):459-465. DOI: 10.1038/s41390-021-01796-w. View

15.

Banks P, Freeman M . Practice guidelines in acute pancreatitis. Am J Gastroenterol. 2006; 101(10):2379-400. DOI: 10.1111/j.1572-0241.2006.00856.x. View

16.

Maxwell R, Cole P . Pharmacogenetic Predictors of Treatment-Related Toxicity Among Children With Acute Lymphoblastic Leukemia. Curr Hematol Malig Rep. 2017; 12(3):176-186. DOI: 10.1007/s11899-017-0376-z. View

17.

Johnson C, Besselink M, Carter R . Acute pancreatitis. BMJ. 2014; 349:g4859. DOI: 10.1136/bmj.g4859. View

18.

Wang G, Gao C, Wei D, Wang C, Ding S . Acute pancreatitis: etiology and common pathogenesis. World J Gastroenterol. 2009; 15(12):1427-30. PMC: 2665136. DOI: 10.3748/wjg.15.1427. View

19.

Flores-Calderon J, Exiga-Gonzalez E, Moran-Villota S, Martin-Trejo J, Yamamoto-Nagano A . Acute pancreatitis in children with acute lymphoblastic leukemia treated with L-asparaginase. J Pediatr Hematol Oncol. 2009; 31(10):790-3. DOI: 10.1097/MPH.0b013e3181b794e8. View

20.

Silverman L, Gelber R, Dalton V, Asselin B, Barr R, Clavell L . Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01. Blood. 2001; 97(5):1211-8. DOI: 10.1182/blood.v97.5.1211. View